Talor Sax

Talor Sax serves as the CEO of eHealth Ventures since January 2015, focusing on digital health investments in early-stage startups. In November 2023, Talor founded the Geshem Impact Fund to support the Israeli high-tech sector, collaborating with 11 Israeli venture capitalists and incubators. As a founding member of the Israeli Telemedicine Community since June 2020, Talor has played a key role in adapting the health system during the COVID-19 pandemic. Talor also holds multiple board positions in companies such as allerguard (Chairman), AccuLine, EfA Technologies, Nervio, Olive Diagnostics, and Ophthalmic Sciences. Educational qualifications include an Executive Education program in Leadership & Change Management from Harvard Business School, an MBA in Health Care Administration from Tel Aviv University, an Executive MBA in Finance from The Hebrew University of Jerusalem, and a Bachelor's degree in Economics and Computer Science from Ben-Gurion University of the Negev.